| Dr Neerav G Sheth, MD | |
|
2 Industrial Blvd Ste 200, Paoli, PA 19301-1648 | |
| (610) 647-4260 | |
| (610) 647-7430 |
| Full Name | Dr Neerav G Sheth |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 17 Years |
| Location | 2 Industrial Blvd Ste 200, Paoli, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679774467 | NPI | - | NPPES |
| 1028289290002 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paoli Hospital | Paoli, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiology Consultants Of Philadelphia Pc | 5294620746 | 126 |
News Archive
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Many research groups have recently explored human adaptation and successfully identified candidate genes to high altitude living among three major far-flung global populations: Tibetans, Ethiopians and Peruvians.
› Verified 9 days ago
| Entity Name | West Chester Cardiology,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932118585 PECOS PAC ID: 2567376916 Enrollment ID: O20031118001146 |
News Archive
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Many research groups have recently explored human adaptation and successfully identified candidate genes to high altitude living among three major far-flung global populations: Tibetans, Ethiopians and Peruvians.
› Verified 9 days ago
| Entity Name | Cardiology Consultants Of Philadelphia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649272386 PECOS PAC ID: 5294620746 Enrollment ID: O20040216000462 |
News Archive
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Many research groups have recently explored human adaptation and successfully identified candidate genes to high altitude living among three major far-flung global populations: Tibetans, Ethiopians and Peruvians.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neerav G Sheth, MD 207 N Broad St Fl 3, Philadelphia, PA 19107-1500 Ph: (610) 647-2400 | Dr Neerav G Sheth, MD 2 Industrial Blvd Ste 200, Paoli, PA 19301-1648 Ph: (610) 647-4260 |
News Archive
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
Many research groups have recently explored human adaptation and successfully identified candidate genes to high altitude living among three major far-flung global populations: Tibetans, Ethiopians and Peruvians.
› Verified 9 days ago
Dr. Scott A. Olex, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 484-565-1510 Fax: 484-565-1513 | |
Matthew Levy, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Industrial Blvd Ste 200, Paoli, PA 19301 Phone: 610-647-2400 Fax: 610-647-3902 | |
Ronald Eric Krauser, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 11 Industrial Blvd., Suite 201, Paoli, PA 19301 Phone: 610-647-2398 Fax: 610-993-2867 | |
Dr. Elliot Mark Gerber, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Medical Office Bldg Ii - Suite 328, Paoli, PA 19301 Phone: 610-647-2400 Fax: 610-647-3902 | |
Leo A Podolsky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Industrial Blvd Ste 200, Paoli, PA 19301 Phone: 610-647-4260 Fax: 610-647-7430 | |
Emre Beken, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 484-565-1513 | |
Dr. Lisa R Kallenbach, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Industrial Blvd, Ste 110, Paoli, PA 19301 Phone: 610-725-0650 Fax: 610-725-9583 |